TIC SCHIZOPRENIA RESTLESS LEGS SYNDROME DISORDERS BEHAVIORAL IMPULS CONTROL DISORDERS PARKINSON S DISEASE ADHD HUNTINGTON S DISEASE
|
|
- Hilda McCoy
- 5 years ago
- Views:
Transcription
1 TIC DISORDERS RESTLESS LEGS SYNDROME SCHIZOPRENIA BEHAVIORAL IMPULS CONTROL DISORDERS PARKINSON S DISEASE ADHD HUNTINGTON S DISEASE E.Ch. Wolters UTRECHT
2 Treatmentof attentiondeficit hyperactivitydisorder with monoamine amino acid (serotonin, dopamine) precursors (tryptophan, tyrosine) and organic cation transporter essay interpretation Marty Hinz, Alvin Stein, Robert Neff, Robert Weinberg, Thomas Uncini Neuropsychiatric Disease and Treatment Dopamine-serotonininteractionsin attention-deficithyperactivitydisorder Robert D. Oades Progress in Brain Research 172;
3 J Psychiatry Neurosci. 2010: Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder Marcel Romanos, MD,* David Weise, MD,* Mira Schliesser, Martin Schecklmann, PhD, Julia Löffler, Andreas Warnke, MD, PhD, Manfred Gerlach, PhD, Joseph Classen, MD, and Claudia Mehler-Wex, MD Visualisation of the mesencephalic scanning plane by transcranial sonography PD CONTROL CONTROL ADHD
4 In adults, an enlarged echogenic substantia nigra area is considered to be a structural marker of dysfunction of the nigrostriatal dopaminergic system. Enlarged echogenicity is associated with presynaptic dopaminergic dysfunction in patients with PD and with the severity of parkinsonism induced by neuroleptics in patients with schizophrenia. SPECT SCANS TO ESTABLISH THE PROGRESSION OF PARKINSON S DISEASE CONTROLE H&J II H&J III H&J IV FP-CIT However, there is still disagreement about how abnormal extension of substantia nigra echogenicity is related to the pathogenic substrate of Parkinson disease. Furthermore, the functional significance of increased substantia nigra echogenicity in children with ADHD is yet unknown.
5 An enlarged echogenic substantia nigra area seems to be related to deposition of iron compounds. Iron is an essential cofactor of tyrosine hydroxylase, and disturbance of its function might result in alterations of dopamine synthesis. Thus, there is a potential basis for an etiological model linking Parkinson disease, schizophrenia and ADHD to iron metabolism with enlarged TCS echogenicity. Recent findings suggest an association between decreased ferritin levels and severity of ADHD symptoms, supporting the notion that iron metabolism might be involved in the pathophysiology of ADHD.
6 The Role of the Basal Ganglia PD-Intrinsic Impulse Control Disorders PD-Multifactorial (intrinsic / extrinsic) Impulse Control Disorders PD-Extrinsic Impulse Control Disorders
7 MOTOR PARKINSONISM MIGHT BE UNDERSTOOD BY A DEGENERATION OF THE DOPAMINE-PRODUCING CELLS IN THE NIGRAL SUBSTANCE leading to a dopaminergic denervation of the basal ganglia C PD EOSINOPHYLIC α SYNUCLEIN AND UBIQUITIN POSITIVE DEPOSITS OF CYTOSCELETAL FRAGMENTS Lewy bodies
8 The role of the basal ganglia comprises (among others) the selection of adequate spontaneous or reactive behaviour to a particular situation within the various parallel cortico-basal ganglia-thalamo-cortical motor, emotiovational and limbic (extrapyramidal) circuits
9 The Role of the Basal Ganglia
10
11 CEREBRAL CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX basal ganglia STN GPe GPi THALAMUS LIMBISCHE CTX STRIATUM INFORMATION OUT OF THE ENVIRONMENT PROGRAMMING OF THE MOTOR CORTEX THE BASAL GANGLIA IS A CEREBRAL CIRCUITRY, MODULATED BY DOPAMINE out of the NIGRAL SUBSTANCE ACTIVATING THE THALAMUS AND MOTOR CORTEX TO PRODUCE SPONTANEOUS BEHAVIOR, ADEQUATELY ADAPTED TO OUR INNER AND OUTER ENVIRONMENT
12 CEREBRAL CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX basal ganglia STN INDIRECT LOOP GPe GPi OUTPUT CENTER THALAMUS LIMBISCHE CTX INPUT CENTER STRIATUM DIRECT LOOP PROGRAMMING OF THE MOTOR CORTEX THE OUTPUT OF THE BASAL GANGLIA IS REGULATED BY THE ACTIVITY WITHIN THE AXONAL CONNECTIONS BETWEEN THE INPUT- AND OUTPUT- CENTERS. S.N. THESE CONNECTIONS ARE PROVIDED BY TWO LOOPS: THE DIRECT LOOP (FLEXIBLE, ADAPTED BEHAVIOR) AND THE INDIRECT LOOP (INFLEXIBLE, RIGID BEHAVIOR)
13 CEREBRAL CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX STN INDIRECT LOOP GPe INFLEXIBLE BEHAVIOR FLEXIBLE BEHAVIOR GPi THALAMUS LIMBISCHE CTX STRIATUM DIRECT LOOP PROGRAMMING MOTOR CORTEX S.N. IN CASE OF A DOPAMINE-DEFICIENCY, DUE TO A DYSBALANCE, THERE WILL BE A LOSS OF NORMAL SPONTANEOUS BEHAVIOR IN CASE OF NORMAL DOPAMINERGIC MODULATION, THERE IS A WELL BALANCED ACTIVITY WITHIN THESE TWO LOOPS THE DIRECT LOOP (FLEXIBLE, ADAPTED BEHAVIOR) and THE INDIRECT LOOP (INFLEXIBLE, RIGID BEHAVIOR) OF THE RESULTING IN A NORMAL, ADAPTED SPONTANEOUS BEHAVIOR
14 CEREBRALE CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX LIMBISCHE CTX STN INDIRECT LOOP GPe INFLEXIBLE BEHAVIOR FLEXIBLE BEHAVIOR GPi STRIATUM DIRECT LOOP S.N. THIS DYSBALANCE INDUCES A NON-ADAPTED, INFLEXIBLE AND ROBOTIC BEHAVIOR THALAMUS PROGRAMMING MOTOR CORTEX OF THE withscarcityof movements, dueto the increasedinhibition the thalamus with excitation of the motor cortex of reduced
15 dopamine-deficiency in the basal ganglia manifests with PARKINSONISM BRADYKINESIA HYPOKINESIA RIGIDITY TREMOR (60%) LOSS OF POSTURAL REFLEXES STOOPED POSTURE The same characteristic hallmarks might be induced in experimental animals by selective lesioning of the nigral substance ROSARIO MORATALLA CAJAL INSTITUTE, MADRID
16 CEREBRALE CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX STN HYPER DIRECT LOOP INDIRECT LOOP GPe INFLEXIBLE BEHAVIOR FLEXIBLE BEHAVIOR REACTIVE BEHAVIOR GPi THALAMUS LIMBISCHE CTX STRIATUM DIRECT LOOP S.N. IN ORDER TO ORCHESTRATE ADEQUATE, FULLY ADAPTED BEHAVIOR, THE OUTPUT OF THE BASAL GANGLIA TO THE THALAMUS AND MOTOR CORTEX IS ALSO INFLUENCED BY AN HYPERDIRECT LOOP, INDUCING REACTIVE BEHAVIOR
17 CEREBRALE CORTEX ASSOCIATIEVE CTX SENSORIMOTORISCHE CTX STN HYPER DIRECT LOOP INDIRECT LOOP GPe INFLEXIBLE BEHAVIOR FLEXIBLE BEHAVIOR REACTIVE BEHAVIOR GPi THALAMUS LIMBISCHE CTX STRIATUM DIRECT LOOP SO, SPONTANEOUS BEHAVIOR WILL BE OVERRULED BY STIMULATING REACTIVE BEHAVIOR S.N. BY GIVING A TASK, AN EXTERNAL CUE OR IN BEHAVIORAL CONDITIONING, THE HYPERDIRECT LOOP WILL BE ACTIVATED, RESULTING IN REACTIVE BEHAVIOR with suppression of the spontaneous behavior
18 INDEED, IN HEALTHY PEOPLE, REACTIVE BEHAVIOR OFTEN TAKES PRIORITY TO SPONTANEOUS BEHAVIOR external cues or conscious cortical enforcement help to induce specifically wanted behavior external rhytms are not only helpful in dancing though also in military and/or religious services Heremans E et al. Brain Research 2009;1278:51-58
19
20 BARRY LEVINSON 1996 SLEEPERS
21 and alsoin PD, conscious cortical enforcement of the emotional/motivational incentives (LURIA: THE NATURE OF HUMAN CONFLICTS, 1932) may compensate forthe dopamine-deficiency induced loss of spontaneous(emotivational) behavior
22
23
24
25 Parkinsonism is not the same as Parkinson s Disease thanks to the new concepts of Heiko Braak, we now better understand the pathophysiology of the various PD-related signs and symptoms
26 PD is a diffuse synucleinopathy within the nervous system with the formation of Lewy bodies starting in the peripheral nervous system and later on in the lower brainstem, advancing in a topographically predictable sequence, to the upper brainstem and finally the cerebral cortex
27 cortical Lewy bodies YEARS STAGE V Lewybodies in the nigral substance 20 STAGE III Lewy neurites in the vagalnerve 10 STAGE I Lewybodies and neuritesin dorsal motor vagalncl. 5 and it may take years before local degeneration passes the critical threshold and becomes clinically overt.. 0
28 PD-RELATED DISORDERS IN THE IMPULSIVE-COMPULSIVE SPECTRUM Dopamine Deficiency Syndrome (DDS-1) Dopamine Dependency Syndrome (DDS-2) Dopamine Dysregulation Syndrome (DDS-3) Impulse Control Disorders (ICD) Obsessive-Compulsive Disorders (OCD) in PD are not described as of yet
29 PD-Intrinsic Impulse Control Disorders the dopamine deficiency syndrome
30 as said before, the most widely accepted model of behavioral disorders suggests an imbalance between the direct and. indirect pathways within the ventral cortico-striatal-thalamo-cortical circuit
31 In PD, due to dopamine deficiency, habitual behavior will suppress emotivational behavior (resulting in apathy and dysphoria, due to not reaching the rewards) and therefore induce habitual behavior with robot-like movements, masked face, loss of body language & arm-swing loss of initiative, apathy, dysphoria, anxiety- and panickattcks, fear, depressive mood may result in mild reward-seeking and immediate gratification behavior DOPAMINE DEFICIENCY SYNDROME (DDS-1)
32 DOPAMINE DEFICIENCY SYNDROME (DDS-1) this immediate reward-seeking behavior will be best treated by optimal dopamine replacement therapy
33 PD-Multifactorial (Intrinsic / Extrinsic) Impulse Control Disorders the dopamine dependency syndrome the dopamine dysregulation syndrome
34 . a maladaptive therapeutic dependence on dopamine replacement therapy, fulfilling operational criteria of substance dependence HYPERMOTIVATION TO TAKE LEVODOPA, SUPPOSEDLY DUE TO INCREASING TOLERANCE TO ITS BENEFICIAL EFFECTS, LEADING TO COMPULSIVE USE AND A DEPENDENCE CONDITION COMPARABLE TO ADDICTION: psychomotor agitation, euphoria, resistance to dose reduction, withdrawal symptoms DOPAMINE DEPENDENCY SYNDROME (DDS-2)
35 DOPAMINE DEPENDENCY SYNDROME (DDS-2) This dopamine dependency syndrome will be best treated by psychosocial interventions and/or mood stabilizers
36 PD-Multifactorial (Intrinsic / Extrinsic) Impulse Control Disorders the dopamine dependency syndrome the dopamine dysregulation syndrome
37 DOPAMINERGIC TERMINALS Dopamine dopamine receptors activated receptor normal function
38 Dopamine from Sinemet or Madopar and/or Dopamine Agonists dopamine receptors DOPAMINERGIC NERVE TERMINALS due to the loss of presynaptic dopaminergic neurons (with wearing-off), during pharmacological treatment, the receptor activation pattern will become discontinuous (pulsatile)
39 excessive pulsatile dopamine receptor stimulation in the long run will lead to behavioral sensitization with hypersensitivity of the dopaminergic receptors in the dorsal motor striatal circuit this will cause hyperkinesia
40
41 excessive pulsatile dopamine receptor stimulation in the long run will lead to behavioral sensitization with hypersensitivity of the dopaminergic receptors in the ventral limbic striatal circuit this will cause punding a kind of compulsive hobbyism: an intense fascination for common objects with repetitive, obsessive, meaningless actions such as cleaning, collecting, dismantling, sorting and/or repairing of those objects DOPAMINE DYSREGULATION SYNDROME (DDS-3)
42
43
44 DOPAMINE DYSREGULATION SYNDROME (DDS-3) hyperkinetic and/or punding behavior will be pharmacodynamically prevented and/or masked by increasing tolerance Continuous Dopaminergic Stimulation
45 CDS INTRADUODENAL INFUSION WITH DUODOPA S.C. APO-GO PUMP WITH APOMORPHINE AND PREFERABLY NOT.. DBS
46 PD-Extrinsic Impulse Control Disorders the impulse control disorders
47 IMPULSE CONTROL DISORDERS Pathological internet use Pathological skin picking Pathological gambling Pathological shopping/buying Binge eating Hypersexuality impulse control disorders are suggested to be adverse side effects of dopamine replacement therapy (D-1 and D-3 > D-2 agonists > levodopa), especially in younger, unmarried, cigarette smoking (PD, RLS) patients with a family history of gambling / substance abuse
48 CEREBRAL CORTEX LIMBIC ASSOCIATIVE SENSORIMOTOR In PD, when the activity of the direct loop prevails HYPER DIRECT PATHWAY STN NO-GO D-2 INDIRECT PATHWAY GPe GPi DIRECT PATHWAY GO D-1 D-3 D-2 STRIATUM D-1 N.S. 1) in HF-STN-DBS reducing STN activity 2) in selective D-1 / D-3 stimulation habitual behavior will be inhibited and allow more emotivational behavior such as stereotyped behavior (punding) impulse control disorders THALAMUS. and of course, in HF-STN-DBS, increased activity in the thalamo-cortical projection may cause mild hyperkinesia NO-GO the indirect D-2 loop facilitating habitual behavior GO the direct D-1 loop facilitating emotivational behavior
49 PATHOLOGICAL GAMBLING a failure to resist gambling impulses despite severe personal or family consequences this condition is associated with young onset PD, higher novelty seeking traits, (familiar) alcoholism and dopamine agonist adjunctive (not mono)therapy
50 PATHOLOGICAL SHOPPING or BUYING pathological shopping and/or buying is characterized by excessive or poorly controlled preoccupations, urges or behaviors, regarding shopping and spending that lead to subjective distress or impaired functioning this condition is associated with (female) gender, mood disorders and substance abuse, deep brain stimulation and dopamine agonists
51 PATHOLOGICAL (BINGE) EATING pathological eating or binge eating is a behavior characterized by eating an amount of food that is definitely larger than most people would eat during the same period of time under similar circumstances and the lack of control over eating (the feeling that one cannot stop eating or control what or how much one is eating) (La grande bouffe)
52 PATHOLOGICAL SEXUAL BEHAVIOUR pathological sexual behavior, mainly satyriasis, is the result of a preoccupation with sexual feelings and thoughts, disrupting normal (marital) lifestyle in many cases, treatment with antipsychotics and/or stopping dopamine agonists is not very helpful, and only the antihormone cyproteron might bring the solution
Anatomy of the basal ganglia. Dana Cohen Gonda Brain Research Center, room 410
Anatomy of the basal ganglia Dana Cohen Gonda Brain Research Center, room 410 danacoh@gmail.com The basal ganglia The nuclei form a small minority of the brain s neuronal population. Little is known about
More informationBasal ganglia Sujata Sofat, class of 2009
Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Objectives Describe the function of the Basal Ganglia in movement Define the BG components and their locations Describe the motor loop of the BG
More informationMaking Things Happen 2: Motor Disorders
Making Things Happen 2: Motor Disorders How Your Brain Works Prof. Jan Schnupp wschnupp@cityu.edu.hk HowYourBrainWorks.net On the Menu in This Lecture In the previous lecture we saw how motor cortex and
More informationGangli della Base: un network multifunzionale
Gangli della Base: un network multifunzionale Prof. Giovanni Abbruzzese Centro per la Malattia di Parkinson e i Disordini del Movimento DiNOGMI, Università di Genova IRCCS AOU San Martino IST Basal Ganglia
More informationCOGNITIVE SCIENCE 107A. Motor Systems: Basal Ganglia. Jaime A. Pineda, Ph.D.
COGNITIVE SCIENCE 107A Motor Systems: Basal Ganglia Jaime A. Pineda, Ph.D. Two major descending s Pyramidal vs. extrapyramidal Motor cortex Pyramidal system Pathway for voluntary movement Most fibers originate
More informationNeurodegenerative Disease. April 12, Cunningham. Department of Neurosciences
Neurodegenerative Disease April 12, 2017 Cunningham Department of Neurosciences NEURODEGENERATIVE DISEASE Any of a group of hereditary and sporadic conditions characterized by progressive dysfunction,
More informationPD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease
PD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease Presented By: Daniel Weintraub, M.D. Associate Professor of Psychiatry, University of Pennsylvania; Parkinson s Disease and
More informationMovement Disorders: A Brief Overview
Movement Disorders: A Brief Overview Albert Hung, MD, PhD Massachusetts General Hospital Harvard Medical School August 17, 2006 Cardinal Features of Parkinsonism Tremor Rigidity Bradykinesia Postural imbalance
More informationParkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.
Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817. Four (4) hallmark clinical signs: 1) Tremor: (Note -
More informationBasal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota
Basal Ganglia Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Graduate School Discussion Wednesday, Nov 1, 11:00am MoosT 2-690 with Paul Mermelstein (invite your friends)
More informationTeach-SHEET Basal Ganglia
Teach-SHEET Basal Ganglia Purves D, et al. Neuroscience, 5 th Ed., Sinauer Associates, 2012 Common organizational principles Basic Circuits or Loops: Motor loop concerned with learned movements (scaling
More informationVL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements
BASAL GANGLIA Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University at Buffalo I) Overview How do Basal Ganglia affect movement Basal ganglia enhance cortical motor activity and facilitate movement.
More informationBasal Ganglia George R. Leichnetz, Ph.D.
Basal Ganglia George R. Leichnetz, Ph.D. OBJECTIVES 1. To understand the brain structures which constitute the basal ganglia, and their interconnections 2. To understand the consequences (clinical manifestations)
More informationDamage on one side.. (Notes) Just remember: Unilateral damage to basal ganglia causes contralateral symptoms.
Lecture 20 - Basal Ganglia Basal Ganglia (Nolte 5 th Ed pp 464) Damage to the basal ganglia produces involuntary movements. Although the basal ganglia do not influence LMN directly (to cause this involuntary
More informationPsychiatric aspects of Parkinson s disease an update
Psychiatric aspects of Parkinson s disease an update Dr Chris Collins 027 2787593 chris.collins@cdhb.health.nz Disclosures: none Non-motor aspects physical Sensory anosmia, visual symptoms Speech and
More informationThe motor regulator. 1) Basal ganglia/nucleus
The motor regulator 1) Basal ganglia/nucleus Neural structures involved in the control of movement Basal Ganglia - Components of the basal ganglia - Function of the basal ganglia - Connection and circuits
More informationTranscranial sonography in movement disorders
Transcranial sonography in movement disorders Uwe Walter 1st Residential Training of the European Society of Neurosonology and Cerebral Hemodynamics September 7-12, 2008 Bertinoro, Italy Department of
More informationTO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE. The statement to be motivated is to have an increase in dopamine implies that an increase in
1 NAME COURSE TITLE 2 TO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE The statement to be motivated is to have an increase in dopamine implies that an increase in dopamine neurotransmitter, up-regulation
More informationUNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PHYSIOLOGY & BIOCHEMISTRY NEUROPHYSIOLOGY (MEDICAL) Spring, 2014
UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PHYSIOLOGY & BIOCHEMISTRY NEUROPHYSIOLOGY (MEDICAL) Spring, 2014 Textbook of Medical Physiology by: Guyton & Hall, 11 th edition 2006 Eman Al-Khateeb,
More informationGBME graduate course. Chapter 43. The Basal Ganglia
GBME graduate course Chapter 43. The Basal Ganglia Basal ganglia in history Parkinson s disease Huntington s disease Parkinson s disease 1817 Parkinson's disease (PD) is a degenerative disorder of the
More informationIII./3.1. Movement disorders with akinetic rigid symptoms
III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.
More informationVisualization and simulated animations of pathology and symptoms of Parkinson s disease
Visualization and simulated animations of pathology and symptoms of Parkinson s disease Prof. Yifan HAN Email: bctycan@ust.hk 1. Introduction 2. Biochemistry of Parkinson s disease 3. Course Design 4.
More informationPARKINSON S MEDICATION
PARKINSON S MEDICATION History 1940 50 s Neurosurgeons operated on basal ganglia. Improved symptoms. 12% mortality 1960 s: Researchers identified low levels of dopamine caused Parkinson s leading to development
More informationExam 2 PSYC Fall (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
Exam 2 PSYC 2022 Fall 1998 (2 points) What 2 nuclei are collectively called the striatum? (2 points) Match a brain structure that is located closest to the following portions of the ventricular system
More informationParkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder
Prevalence Parkinson s Disease Mark S. Baron, M.D. Associate Professor of Neurology Movement Disorders Section VCU School of Medicine Common disorder Approaching 1% by 65 yrs of age, 2% by 80 yrs of age
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationBehavioral Aspects of Parkinson s Disease
Behavioral Aspects of Parkinson s Disease Joseph H. Friedman, MD Director, Movement Disorders Program Butler Hospital Dept of Neurology Alpert Medical School of Brown University 1 Disclosures Drugs will
More informationConnections of basal ganglia
Connections of basal ganglia Introduction The basal ganglia, or basal nuclei, are areas of subcortical grey matter that play a prominent role in modulating movement, as well as cognitive and emotional
More informationASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE
ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging Dr. Olav E. Krigolson krigolson@uvic.ca Lecture 5: PARKINSONS DISEASE The Basal Ganglia Primary motor cortex Execution of movement
More informationA. General features of the basal ganglia, one of our 3 major motor control centers:
Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. March 1, 2012 THE BASAL GANGLIA Objectives: 1. What are the main
More information05-Nov-15. Impact of Parkinson s Disease in Australia. The Nature of Parkinson s disease 21st Century
Peter Silburn Professor Clinical Neuroscience University of Queensland Queensland Brain Institute Neurosciences Queensland Impact of in Australia Second most common neurodegenerative disorder Up to 64,000
More informationScott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE
Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE LEARNING OBJECTIVES The Course Participant will: 1. Be familiar with the pathogenesis of Parkinson s Disease (PD) 2. Understand clinical
More informationA. General features of the basal ganglia, one of our 3 major motor control centers:
Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. April 22, 2010 THE BASAL GANGLIA Objectives: 1. What are the
More informationFirst described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy"
Parkinson's Disease First described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy" Parkinson s disease (PD) is a neurological disorder characterized by a progressive
More informationBasal Ganglia. Today s lecture is about Basal Ganglia and it covers:
Basal Ganglia Motor system is complex interaction between Lower motor neurons (spinal cord and brainstem circuits) and Upper motor neurons (pyramidal and extrapyramidal tracts) plus two main regulators
More informationIdentification and Management of Impulse Control Disorders Among Individuals with Parkinson s Disease
Movement Disorders Identification and Management of Impulse Control Disorders Among Individuals with Parkinson s Disease Abstract Although Parkinson s disease is primarily considered to be a motor disorder,
More informationnucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
Nucleus accumbens From Wikipedia, the free encyclopedia Brain: Nucleus accumbens Nucleus accumbens visible in red. Latin NeuroNames MeSH NeuroLex ID nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
More informationMaking Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease
Making Every Little Bit Count: Parkinson s Disease SHP Neurobiology of Development and Disease Parkinson s Disease Initially described symptomatically by Dr. James Parkinson in 1817 in An Essay on the
More informationChapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.
Chapter 8 Parkinsonism M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Definition of Parkinson s Disease Parkinson's disease is a progressive, neurodegenerative disease
More informationStrick Lecture 4 March 29, 2006 Page 1
Strick Lecture 4 March 29, 2006 Page 1 Basal Ganglia OUTLINE- I. Structures included in the basal ganglia II. III. IV. Skeleton diagram of Basal Ganglia Loops with cortex Similarity with Cerebellar Loops
More informationParkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.
Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O. Parkinson s Epidemiology AFFECTS 1% OF POPULATION OVER 65 MEAN AGE OF ONSET 65 MEN:WOMEN 1.5:1 IDIOPATHIC:HEREDITARY 90:10
More informationBasal Ganglia. Introduction. Basal Ganglia at a Glance. Role of the BG
Basal Ganglia Shepherd (2004) Chapter 9 Charles J. Wilson Instructor: Yoonsuck Choe; CPSC 644 Cortical Networks Introduction A set of nuclei in the forebrain and midbrain area in mammals, birds, and reptiles.
More informationDr Barry Snow. Neurologist Auckland District Health Board
Dr Barry Snow Neurologist Auckland District Health Board Dystonia and Parkinson s disease Barry Snow Gowers 1888: Tetanoid chorea Dystonia a movement disorder characterized by sustained or intermittent
More informationParkinson s Disease Duncan Gerry. 5/12/12 All drugs are poison
Parkinson s Disease Duncan Gerry 5/12/12 All drugs are poison Order of the Day Current and future of PD service in Hillingdon Case history highlighting the complexity of management, presentation and some
More informationPathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits
More informationneuropsychiatric effects of subthalamic neurostimulation in Parkinson disease
reviews neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease Jens Volkmann, Christine Daniels and Karsten Witt Abstract Neurostimulation of the subthalamic nucleus (STN) is an
More informationThe Wonders of the Basal Ganglia
Basal Ganglia The Wonders of the Basal Ganglia by Mackenzie Breton and Laura Strong /// https://kin450- neurophysiology.wikispaces.com/basal+ganglia Introduction The basal ganglia are a group of nuclei
More informationThe Nervous System Mark Stanford, Ph.D.
The Nervous System Functional Neuroanatomy and How Neurons Communicate Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Addiction Medicine and Therapy Services The Nervous System In response
More informationImpulse control disorders in Parkinson s disease
Impulse control disorders in Parkinson s disease Impulsivity and impulse control disorders in Parkinson s disease A pilot study of assessment instruments in a clinic population Student thesis, Institute
More informationFunctional Distinctions
Functional Distinctions FUNCTION COMPONENT DEFICITS Start Basal Ganglia Spontaneous Movements Move UMN/LMN Cerebral Cortex Brainstem, Spinal cord Roots/peripheral nerves Plan Cerebellum Ataxia Adjust Cerebellum
More informationExtrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010
Extrapyramidal Motor System Basal Ganglia or Striatum Descending extrapyramidal paths receive input from other parts of motor system: From the cerebellum From the basal ganglia or corpus striatum Caudate
More informationDISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine
DISORDERS OF THE MOTOR SYSTEM Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine THE MOTOR SYSTEM To understand disorders of the motor system, we need to review how a
More informationSTRUCTURE AND CIRCUITS OF THE BASAL GANGLIA
STRUCTURE AND CIRCUITS OF THE BASAL GANGLIA Rastislav Druga Department of Anatomy, Second Faculty of Medicine 2017 Basal ganglia Nucleus caudatus, putamen, globus pallidus (medialis et lateralis), ncl.
More informationParkinson's Disease KP Update
Parkinson's Disease KP Update Andrew Imbus, PA-C Neurology, Movement Disorders Kaiser Permanente, Los Angeles Medical Center No disclosures "I often say now I don't have any choice whether or not I have
More informationEvaluation of Parkinson s Patients and Primary Care Providers
Evaluation of Parkinson s Patients and Primary Care Providers 2018 Movement Disorders Half Day Symposium Elise Anderson MD Medical Co-Director, PBSI Movement Disorders 6/28/2018 1 Disclosures GE Speaker,
More informationMargo J Nell Dept Pharmacology
Margo J Nell Dept Pharmacology 1 The extra pyramidal system Separation of cortico-spinal system (pyramidal system, (PS)) from the basal ganglia (extra pyramidal motor system (EPS)) because they produce
More informationEvaluation and Management of Parkinson s Disease in the Older Patient
Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of
More informationHuntington s Disease COGS 172
Huntington s Disease COGS 172 Overview Part I: What is HD? - Clinical description and features - Genetic basis and neuropathology - Cell biology, mouse models and therapeutics Part II: HD as a model in
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationBASAL GANGLIA AN INTEGRATIVE VIEW
BASAL GANGLIA AN INTEGRATIVE VIEW Edited by Fernando A. Barrios and Clemens Bauer BASAL GANGLIA AN INTEGRATIVE VIEW Edited by Fernando A. Barrios and Clemens Bauer Basal Ganglia An Integrative View http://dx.doi.org/10.5772/2976
More informationCorrelates of Tic Disorders. Hyperactivity / motor restlessness Inattentiveness Anxiety Aggression Other
Tourette Disorder Rarely present in pure form No two individuals with TD are the same Often associated with other symptoms, which may be more disabling than the tics themselves Treatments need to target
More informationMoving fast or moving slow: an overview of Movement Disorders
Moving fast or moving slow: an overview of Movement Disorders Mini Medical School October 25, 2018 Heather Rigby, MD, FRCPC 2014 MFMER slide-1 2014 MFMER slide-2 Basal Ganglia Dysfunction - Movement Disorders
More information- Neurotransmitters Of The Brain -
- Neurotransmitters Of The Brain - INTRODUCTION Synapsis: a specialized connection between two neurons that permits the transmission of signals in a one-way fashion (presynaptic postsynaptic). Types of
More informationParkinson s Disease Psychosis Treatment in Long-Term Care: Clinical and Operational Considerations
Parkinson s Disease Psychosis Treatment in Long-Term Care: Clinical and Operational Considerations Pari Deshmukh MD Triple board-certified psychiatrist (Boards of psychiatry, addiction medicine, integrative
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More informationTHE BRAIN HABIT BRIDGING THE CONSCIOUS AND UNCONSCIOUS MIND. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
THE BRAIN HABIT BRIDGING THE CONSCIOUS AND UNCONSCIOUS MIND Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Linking thought and movement simultaneously! Forebrain Basal ganglia Midbrain and
More informationDRUG TREATMENT OF PARKINSON S DISEASE. Mr. D.Raju, M.pharm, Lecturer
DRUG TREATMENT OF PARKINSON S DISEASE Mr. D.Raju, M.pharm, Lecturer PARKINSON S DISEASE (parkinsonism) is a neurodegenerative disorder which affects t h e b a s a l g a n g l i a - and is associated with
More informationBasal Ganglia General Info
Basal Ganglia General Info Neural clusters in peripheral nervous system are ganglia. In the central nervous system, they are called nuclei. Should be called Basal Nuclei but usually called Basal Ganglia.
More informationComputational cognitive neuroscience: 8. Motor Control and Reinforcement Learning
1 Computational cognitive neuroscience: 8. Motor Control and Reinforcement Learning Lubica Beňušková Centre for Cognitive Science, FMFI Comenius University in Bratislava 2 Sensory-motor loop The essence
More informationNon-Motor Symptoms of Parkinson s Disease
Non-Motor Symptoms of Parkinson s Disease Samantha Holden, MD University of Colorado Movement Disorders MOTOR SYMPTOMS Rigidity Bradykinesia Tremor Gait Imbalance NON-MOTOR SYMPTOMS Dementia Urinary frequency
More informationHow to Effectively Manage the Motor Symptoms of HD
How to Effectively Manage the Motor Symptoms of HD Yvette Bordelon, MD, PhD Associate Clinical Professor of Neurology David Geffen School of Medicine at UCLA The information provided by speakers in workshops,
More informationParkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee
Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is
More informationLet s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016
Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016 What is Parkinson s? Parkinson's is a progressive neurological condition. People
More informationOverview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits
Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:
More informationLecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!
Lecture XIII. Brain Diseases I - Parkinsonism! Bio 3411! Wednesday!! Lecture XIII. Brain Diseases - I.! 1! Brain Diseases I! NEUROSCIENCE 5 th ed! Page!!Figure!!Feature! 408 18.9 A!!Substantia Nigra in
More informationBiological Bases of Behavior. 8: Control of Movement
Biological Bases of Behavior 8: Control of Movement m d Skeletal Muscle Movements of our body are accomplished by contraction of the skeletal muscles Flexion: contraction of a flexor muscle draws in a
More informationDOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD
DOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD Acknowledgments Human Neurochemical Pathology Lab Stephen J. Kish, PhD Jun Chao Tong, PhD Centre for Movement Disorders
More informationDrug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Drug Therapy of Parkinsonism Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Parkinsonism is a progressive neurological disorder of muscle movement, usually
More informationOptimizing Clinical Communication in Parkinson s Disease:
Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of
More informationMotor Fluctuations in Parkinson s Disease
Motor Fluctuations in Parkinson s Disease Saeed Bohlega, MD, FRCPC Senior Distinguished Consultant Department of Neurosciences King Faisal Specialist Hospital & Research Centre Outline Type of fluctuations
More informationChemical Control of Behavior and Brain 1 of 9
Chemical Control of Behavior and Brain 1 of 9 I) INTRO A) Nervous system discussed so far 1) Specific 2) Fast B) Other systems extended in space and time 1) Nonspecific 2) Slow C) Three components that
More informationSynapse. 1. Presynaptic Terminal Button 2. Postsynaptic Membrane 3. Vesicles 4. Synaptic Cleft 5. Neurotransmitters 6.
Synapse 1. Presynaptic Terminal Button 2. Postsynaptic Membrane 3. Vesicles 4. Synaptic Cleft 5. Neurotransmitters 6. Receptor Sites For communication between neurons to occur, an electrical impulse must
More informationThe Shaking Palsy of 1817
The Shaking Palsy of 1817 A Treatment Update on Parkinson s Disease Dr Eitzaz Sadiq Neurologist CH Baragwanath Acadamic Hospital Parkinson s Disease O Premature death of dopaminergic neurons O Symptoms
More informationCourse Calendar - Neuroscience
2006-2007 Course Calendar - Neuroscience Meeting Hours for entire semester: Monday - Friday 1:00-2:20 p.m. Room 1200, COM August 28 August 29 August 30 August 31 September 1 Course introduction, Neurocytology:
More informationImaging biomarkers for Parkinson s disease
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 6 MDS-ES/EAN: Neuroimaging in movement disorders - Level 2 Imaging biomarkers for Parkinson
More informationClinical Features and Treatment of Parkinson s Disease
Clinical Features and Treatment of Parkinson s Disease Richard Camicioli, MD, FRCPC Cognitive and Movement Disorders Department of Medicine University of Alberta 1 Objectives To review the diagnosis and
More informationElements for a public summary
VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Parkinson s disease affects individuals globally (WHO 2006). It is the most common serious movement disorder, including speech
More informationSubthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about
More informationPharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology
+ Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Overview n Brief review of Parkinson s disease (PD) n Clinical manifestations n Pathophysiology
More informationBest Medical Treatments for Parkinson s disease
Best Medical Treatments for Parkinson s disease Bernadette Schöneburg, M.D. June 20 th, 2015 What is Parkinson s Disease (PD)? Progressive neurologic disorder that results from the loss of specific cells
More informationUpdate on Parkinson s disease and other Movement Disorders October 2018
Update on Parkinson s disease and other Movement Disorders October 2018 DR. JONATHAN EVANS CONSULTANT IN NEUROLOGY QUEEN S MEDICAL CENTRE NOTTINGHAM Disclosures: Honoraria UCB, Britannia, Allergan, AbbVie
More informationPresented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn
Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn Objectives What agents do we currently have available and what do we ideally need? What biomarkers exist for
More informationCN V! touch! pain! Touch! P/T!
CN V! touch! pain! Touch! P/T! Visual Pathways! L! R! B! A! C! D! LT! E! F! RT! G! hypothalamospinal! and! ALS! Vestibular Pathways! 1. Posture/Balance!!falling! 2. Head Position! 3. Eye-Head Movements
More informationThe Parkinson s You Can t See
The Parkinson s You Can t See We principally see the motor phenomena of Parkinson's disease, but is there an early stage without visible features? Might this provide a window for disease-modifying therapy?
More informationCourse Calendar
Clinical Neuroscience BMS 6706C Charles, Ph.D., Course Director charles.ouimet@med.fsu.edu (850) 644-2271 2004 2005 Course Calendar Click here to return to the syllabus Meeting Hours for entire semester:
More informationClinical applications of real-time fmri neurofeedback in 6 steps
Training course: Real-time fmri: Fundamental Principles for Clinical Applications Clinical applications of real-time fmri neurofeedback in 6 steps David Linden Cardiff University 1) What is your clinical
More informationPharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology
+ Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Disclosures n NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT + Learning
More informationThe Adolescent Developmental Stage
The Adolescent Developmental Stage o Physical maturation o Drive for independence o Increased salience of social and peer interactions o Brain development o Inflection in risky behaviors including experimentation
More informationFor more information about how to cite these materials visit
Author(s): Peter Hitchcock, PH.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More information